ACE and chronic kidney disease: Furthermore, we recently found that in a cohort of CKD patients receiving an angiotensin receptor blocker in addition to an angiotensin converting enzyme inhibitor, urinary excretion of proximal tubular markers was reduced, but inflammatory markers did not change (data submitted).